Related Experiment Video
Updated: Jul 7, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Advances in FIV vaccine technology
Elizabeth W Uhl1, Marcus Martin, James K Coleman
1Department of Veterinary Pathology, College of Veterinary Medicine, University of Georgia, 501 DW Brooks Drive, Athens, GA 30602-7388, USA.
Veterinary Immunology and Immunopathology
|February 26, 2008
Summary
This review covers advances in feline immunodeficiency virus (FIV) vaccine technology, comparing it to human immunodeficiency virus (HIV-1) vaccine development. It highlights progress in vaccine design, efficacy assessment, and understanding immunity for better protection.
Area of Science:
- Veterinary Virology
- Immunology
- Vaccine Technology
Background:
- Feline immunodeficiency virus (FIV) vaccine development parallels human immunodeficiency virus (HIV-1) vaccine research.
- Technological progress in molecular techniques and efficacy assessment enhances vaccine characterization.
- Understanding vaccine-induced immunity is crucial for correlating protection.
Purpose of the Study:
- To review technological advancements in FIV vaccine design and efficacy assessment.
- To discuss the characterization of vaccine-induced immunity in FIV.
- To compare FIV vaccine development and outcomes with HIV-1 research.
Main Methods:
- Review of scientific literature on FIV and HIV-1 vaccine development.
- Analysis of technological progress in vaccine design and molecular techniques.
- Evaluation of methods for assessing vaccine efficacy and challenge infection.
Main Results:
- FIV vaccine technology has advanced significantly, sometimes exceeding HIV-1 vaccine development.
- Licensed FIV vaccines demonstrate the progress in this field.
- Characterization of immunity provides insights into protection levels.
Conclusions:
- Technological innovations are driving progress in FIV vaccine development.
- Comparative analysis with HIV-1 provides valuable context for FIV research.
- Improved understanding of FIV immunity is key to developing more effective vaccines.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:51Vaccinations
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...